
Treatment   |  Growth   |  Strategy
 LIVE ONLINE 16 November 2020
Bio Integrates Speakers 2020

STEVE BATES
Chief Executive Officer
UK Bioindustry Association

SEAN MARETT
Chief Business & Commercial Officer
BioNTech

THEO HAROLD
Chief Executive Officer
Crescendo Biologics

CLIVE DIX
Chief Executive Officer
C4X Discovery

STEVE HARRIS
Chairman
Synchrony Pharma

KARIN SCHMITT
Chief Business Officer
Mogrify

IAN CAMPBELL
Interim Executive Chair
Innovate UK

PRIYA MANDE
Chief Operating Officer
PsiOxus Therapeutics

TOBY REID
Chief Executive Officer
BioCity Group

ZUZANNA BRZOSKO
Co-founder and Chief Executive Officer
Sixfold Bioscience

JOHN DAWSON
Chief Executive Officer
Oxford Biomedica

RICHARD WEAVER
Founder and Managing Director
Xenogesis

KEITH THOMPSON
Chair, Pharma Advisory Board
Deep Science Ventures

ZAHID LATIF
Innovation Specialist, Life Sciences Organisation, International Trade & Investment Group
Department for International Trade

KEVIN COX
Chair
ValiRx

JASON MELLAD
Chief Executive Officer
Start Codon

GLENN CROCKER
Head of Life Sciences, JLL & Chairman, BioCity Group
JLL & BioCity Group

SALLY WATERMAN
Chief Operating Officer, Medherant
Sixfold Bioscience

CHRIS TORRANCE
Chief Executive Officer
PhoreMost

BARBARA DOMAYNE-HAYMAN
Entrepreneur-in-residence
Francis Crick Institute

MICHAEL BENNETT
Director of Business Development
Cell and Gene Therapy Catapult

JASON LACOMBE
Chief Executive Officer
Veratrak

DARREN CLARK
Chief Executive
Medilink Midlands

MAUREEN COLEMAN
Chair
CN BioInnovations

ALLAN MARCHINGTON
Managing Partner & Senior Advisor
Bridge Valley Ventures & Apposite Capital

TONY JONES
Chief Executive Officer
One Nucleus

GEOFF DAVISON
Chief Executive Officer
Bionow

SALLY ANN FORSYTH
Chief Executive Officer
Stevenage Bioscience Catalyst

GERALD LAW
Chief Executive
Innovation DB

THOMAS OGORKA
Chief Executive Officer
Orphan Reach

MAIREADH PEDERSEN
Chief Executive Officer
QuayPharma

JESÚS ZURDO
Global Head Bioproduction
Horizon Discovery

EMMA BANKS
Managing Director
ramarketing

RICHARD BUTT
Chief Executive Officer
Apollo Therapeutics

JENNY LAIRD
Vice President, Search & Evaluation Pain & Neurodegeneration
Eli Lilly and Company

JAMES SPICER
Professor of Experimental Cancer Medicine
King’s College London

MARK LEES
Vice President – Corporate Strategy and Operations
Mestag Therapeutics

NICOLA HERON
Head of Collaborative R&D
Medicines Discovery Catapult

DANIEL SMITH
Chief Scientific Officer & Industry Professor, School of Life Science
Cobra Biologics & University of Warwick

CLAIRE THOMPSON
Chief Executive Officer
Agility Life Sciences

CHRISTIAN JONES
Chief Commercial Officer
Nanoform

TERESA LAVOIE
Principal
Fish & Richardson

JOANNA GOULD
Chief Executive Officer and Co-founder
VisusNano

MAYER SCHREIBER
Chief Executive Officer
Discovery Park

JO CRAIG
Senior Vice President CMC
NeRRe Therapeutics

ELISABETH GOODMAN
Owner and Principal Consultant
RiverRhee Consulting

FAZ CHOWDHURY
Chairman and Chief Executive Officer
Nemaura

PAUL STOTT
Chief Executive Officer
Seda Pharmaceutical Development Services

EDDY LITTLER
Chief Operating Officer
ReViral

NICK JOHNSON
Chief Strategy Officer
Cell and Gene Therapy Catapult

STEPHEN TOOKER
Vice President, Commercial Packaging – Europe
PCI Pharma Services

DEREK JONES
Chief Executive Officer
Seda Pharmaceutical Development Services

KATH MACKAY
Managing Director
Bruntwood SciTech – Alderley Park

JOE DE SOUSA
Senior Leader, Non-Exec Director and Independent Consultant
Melhor Consulting

NEIL HAWKINS
Partner & Director | Professor of Health Technology Assessment
Visible Analytics | University of Glasgow

ROS HANNEN
Chief Executive Officer
Keratify

FLIC GABBAY
Managing Partner
tranScrip

BEVERLEY CARR
Chief Business Officer
Achilles

DECLAN JONES
Vice President and Head of External Innovation (EI) and Scientific Licensing
Ferring Research Institute

DETLEF BEHRENS
Managing Director
Bay Pharma

EUAN CAMERON
Chief Executive Officer & Founder
COHESION Medical

ALLAN JORDAN
Director of Oncology Drug Discovery
Sygnature Discovery

EDDIE BLAIR
Chairman
Virokine Therapeutics

LAURA ITZHAKI
Chief Scientific Officer
PolyProx Therapeutics

MIKE SNOWDEN
Senior Vice President Discovery Sciences, Biopharmaceuticals R&D
AstraZeneca

CLARE TERLOUW
Head of Ventures
LifeArc

CHARLES STEWARD
Patient Advocacy and Engagement Lead
Congenica

JONATHAN APPLEBY
Chief Scientific Officer
Cell and Gene Therapy Catapult (CGT Catapult)

DOUG CUFF
Vice President of U.K. Real Estate
IQHQ

KARL KEEGAN
Chief Executive Officer, Non-Executive Director
Hox Therapeutics Ltd, Nuformix Plc and Novai Ltd.

CHRISTOPHE MULLER
Global Head, Business Development
Evotec (UK) Ltd

RICHARD HEBDON
Head of Health & Medicine, Ageing Society, Health & Nutrition Sector
Innovate UK

TIM LUKER
Vice President Emerging Technology and Innovation
Eli Lilly

HELEN BARKER
Head of Pharmaceutical Development
Reneo Pharma

ROGER KILBURN
Chief Executive Officer
Arcinova

NATALIA NOVAC
Senior Director, Emerging Technology & Innovation, Corporate Business Development
Eli Lilly

SHARON BROWNLOW
Chief Business Officer
Cell & Gene Therapy Catapult

JASON CAMERON
Senior Vice President, Global Technical Operations
Amicus Therapeutics

NOOR SHAKER
Chief Executive Officer
GlamorousAI

OLIVIA CHAMPION
Founder and Chief Executive Officer
BioSystems Technology

LUCY FOLEY
Director of Biologics
CPI

JAY STELLA
Chief Business Officer
Sai Life Sciences

SAMUEL NEILL
Business Development Manager
CPI

JONAS MOLLER
Chief Executive Officer
Albumedix

ANNA PERDRIX ROSELL
Co-founder and Managing Director
Sixfold Bioscience

MICHAEL HUNT
Chief Financial Officer
ReNeuron Group plc

TOM MANDER
Chief Operating Officer
Domainex

JAN THIRKETTLE
Chief Development Officer
Freeline

CAMPBELL BUNCE
Chief Scientific Officer
Abzena

KRISHNA KANUMURI
Managing Director & Chief Executive Officer
Sai Life Sciences

ELIOT FORSTER
Chief Executive Officer
F-star

WILL BROOKS
Investment Director
Downing
Valued silver sponsorsÂ

Treatment   |  Growth   |  Strategy